Eiry Roberts - 22 May 2026 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Reporting relationship: Director
Issuer ticker: BHC
Reported as of: 22 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 May 2026, 19:02:25 UTC
Prior SEC filing: 20 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Brianna M. Dorsi, attorney-in-fact

Key filing fact

Eiry Roberts filed Form 4 for Bausch Health Companies Inc. (BHC) on 26 May 2026.

Key facts

This page summarizes Eiry Roberts's Form 4 filing for Bausch Health Companies Inc. (BHC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 May 2026, 19:02.

Change

Previous filing in this sequence was filed on 20 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001727606 Primary reporting owner

ROBERTS EIRY

Relationship: Director
Address: 400 SOMERSET CORPORATE BLVD, BRIDGEWATER
Signature: /s/ Brianna M. Dorsi, attorney-in-fact
Signature date: 26 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BHC transaction

Common Shares, No Par Value

Award

Transaction value
Shares: +45,871
Change %
Price: $0.000000^*
Shares after: 45,871
Date: 22 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.